Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07443254Phase 2Recruiting
A Phase 2 trial of ketamine in sedation, sponsored by CAMC Health System. Started Mar 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07443254.